REBECCA ZUNIGA: Open Payments
NPI 1124711924 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$218 in 12 payments from 7 companies in 2025. Trend: 2023 $112 · 2024 $177 · 2025 $218
Food & beverage: $218
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| CVRx, Inc. | 1 | $21 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Boston Scientific Corporation | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: REPATHA, CAMZYOS, JARDIANCE, Barostim Neo System, VERQUVO, WATCHMAN Access System, NEXLETOL.
Industry payments across GA — which companies pay providers there.
